259 related articles for article (PubMed ID: 23470966)
21. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
[TBL] [Abstract][Full Text] [Related]
22. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
23. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
24. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
Dong D; Ko B; Baumeister P; Swenson S; Costa F; Markland F; Stiles C; Patterson JB; Bates SE; Lee AS
Cancer Res; 2005 Jul; 65(13):5785-91. PubMed ID: 15994954
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Peptides Targeting Metastatic Tumor Cells as Probes for Cancer Detection and Vehicles for Therapy Delivery.
Subramanian S; Daquinag AC; AghaAmiri S; Ghosh SC; Azhdarinia A; Kolonin MG
Cancer Res; 2021 Nov; 81(22):5756-5764. PubMed ID: 34607842
[TBL] [Abstract][Full Text] [Related]
26. Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy.
Wang SH; Lee AC; Chen IJ; Chang NC; Wu HC; Yu HM; Chang YJ; Lee TW; Yu JC; Yu AL; Yu J
Biomaterials; 2016 Jul; 94():31-44. PubMed ID: 27088408
[TBL] [Abstract][Full Text] [Related]
27. ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer.
Huang KC; Chiang SF; Yang PC; Ke TW; Chen TW; Lin CY; Chang HY; Chen WT; Chao KC
J Cell Physiol; 2021 Sep; 236(9):6481-6495. PubMed ID: 33580514
[TBL] [Abstract][Full Text] [Related]
28. A computational peptide model induces cancer cells' apoptosis by docking Kringle 5 to GRP78.
Khater I; Nassar A
BMC Mol Cell Biol; 2023 Aug; 24(1):25. PubMed ID: 37553635
[TBL] [Abstract][Full Text] [Related]
29. Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70.
Li M; Wang J; Jing J; Hua H; Luo T; Xu L; Wang R; Liu D; Jiang Y
J Cell Mol Med; 2009; 13(11-12):4540-50. PubMed ID: 19017364
[TBL] [Abstract][Full Text] [Related]
30. Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer.
Tang H; Peng F; Huang X; Xie X; Chen B; Shen J; Gao F; You J; Xie X; Chen J
Curr Cancer Drug Targets; 2018; 18(4):390-399. PubMed ID: 28914191
[TBL] [Abstract][Full Text] [Related]
31. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
[TBL] [Abstract][Full Text] [Related]
32. Tunicamycin-induced ER stress in breast cancer cells neither expresses GRP78 on the surface nor secretes it into the media.
Serrano-Negrón JE; Zhang Z; Rivera-Ruiz AP; Banerjee A; Romero-Nutz EC; Sánchez-Torres N; Baksi K; Banerjee DK
Glycobiology; 2018 Feb; 28(2):61-68. PubMed ID: 29206917
[TBL] [Abstract][Full Text] [Related]
33. Human neural stem cell tropism to metastatic breast cancer.
Zhao D; Najbauer J; Annala AJ; Garcia E; Metz MZ; Gutova M; Polewski MD; Gilchrist M; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2012 Feb; 30(2):314-25. PubMed ID: 22084033
[TBL] [Abstract][Full Text] [Related]
34. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
[TBL] [Abstract][Full Text] [Related]
35. Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells.
Backer JM; Krivoshein AV; Hamby CV; Pizzonia J; Gilbert KS; Ray YS; Brand H; Paton AW; Paton JC; Backer MV
Neoplasia; 2009 Nov; 11(11):1165-73. PubMed ID: 19881952
[TBL] [Abstract][Full Text] [Related]
36. GRP78 enabled micelle-based glioma targeted drug delivery.
Ran D; Mao J; Shen Q; Xie C; Zhan C; Wang R; Lu W
J Control Release; 2017 Jun; 255():120-131. PubMed ID: 28344016
[TBL] [Abstract][Full Text] [Related]
37. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
38. Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway.
Xie J; Tao ZH; Zhao J; Li T; Wu ZH; Zhang JF; Zhang J; Hu XC
Biochem Biophys Res Commun; 2016 Jun; 474(3):612-619. PubMed ID: 27012209
[TBL] [Abstract][Full Text] [Related]
39. The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.
Chen L; Li C; Zhu Y
Oncotarget; 2015 Oct; 6(30):30088-101. PubMed ID: 26254225
[TBL] [Abstract][Full Text] [Related]
40. The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis.
Kuang XY; Jiang HS; Li K; Zheng YZ; Liu YR; Qiao F; Li S; Hu X; Shao ZM
Cancer Lett; 2016 Jul; 377(1):87-96. PubMed ID: 27130664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
